Literature DB >> 19446338

The human CD6 gene is transcriptionally regulated by RUNX and Ets transcription factors in T cells.

Mònica Arman1, Noemí Aguilera-Montilla, Virgínia Mas, Amaya Puig-Kröger, Miguel Pignatelli, Roderic Guigó, Angel-Luis Corbí, Francisco Lozano.   

Abstract

CD6 is a lymphocyte surface receptor involved in lymphocyte activation and differentiation processes that is constitutively expressed on developing and mature T cells and on the B1a cells. To define the molecular basis for the tissue-specific expression of CD6 we have identified the transcription factors that control the activity of the proximal regulatory region of the human CD6 gene. The TATA-less CD6 promoter contains multiple transcriptional start sites, and its preferential activity in human T lymphocytes is dependent on RUNX- and Ets-binding sites located within a highly conserved region. RUNX and Ets-1 factors transactivated the CD6 promoter through recognition of the -215 and -230 binding sites, respectively. Chromatin immunoprecipitation assays revealed that RUNX1 constitutively occupies the CD6 promoter in vivo, and knockdown experiments demonstrated that the steady-state level of CD6 mRNA is dependent on the expression of RUNX1, RUNX3 and Ets-1 transcription factors. Therefore, RUNX1/3 and Ets1 control the expression of CD6 in human T lymphocytes, thus expanding the range of T-cell specific and developmentally regulated lymphocyte gene targets involved in T-cell activation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446338     DOI: 10.1016/j.molimm.2009.04.018

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction?

Authors:  N C Derecki; E Privman; J Kipnis
Journal:  Mol Psychiatry       Date:  2010-02-23       Impact factor: 15.992

2.  Transformation of a transposon into a derived prolactin promoter with function during human pregnancy.

Authors:  Deena Emera; Günter P Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

3.  Exploration of the pathogenesis of Sjögren's syndrome via DNA methylation and transcriptome analyses.

Authors:  Yu Du; Jie Li; Jianhong Wu; Fanxin Zeng; Chengsong He
Journal:  Clin Rheumatol       Date:  2022-05-13       Impact factor: 3.650

4.  Molecular basis of ocean acidification sensitivity and adaptation in Mytilus galloprovincialis.

Authors:  Lydia Kapsenberg; Mark C Bitter; Angelica Miglioli; Clàudia Aparicio-Estalella; Carles Pelejero; Jean-Pierre Gattuso; Rémi Dumollard
Journal:  iScience       Date:  2022-06-27

5.  RUNX3 regulates intercellular adhesion molecule 3 (ICAM-3) expression during macrophage differentiation and monocyte extravasation.

Authors:  Ana Estecha; Noemí Aguilera-Montilla; Paloma Sánchez-Mateos; Amaya Puig-Kröger
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

6.  Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases.

Authors:  Ruby Alonso-Ramirez; Séverine Loisel; Caroline Buors; Jacques-Olivier Pers; Enrique Montero; Pierre Youinou; Yves Renaudineau
Journal:  Arthritis       Date:  2011-02-10

7.  Functional interplay between p63 and p53 controls RUNX1 function in the transition from proliferation to differentiation in human keratinocytes.

Authors:  I Masse; L Barbollat-Boutrand; M Molina; O Berthier-Vergnes; N Joly-Tonetti; M T Martin; C Caron de Fromentel; J Kanitakis; J Lamartine
Journal:  Cell Death Dis       Date:  2012-06-07       Impact factor: 8.469

8.  Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.

Authors:  Songnan Sui; Zhiyan Li; Jiaxiong Tan; Liang Wang; Gengxin Luo; Chengwu Zeng; Oscar Junhong Luo; Cunte Chen; Yangqiu Li
Journal:  J Oncol       Date:  2022-08-09       Impact factor: 4.501

9.  Runx3-mediated transcriptional program in cytotoxic lymphocytes.

Authors:  Joseph Lotem; Ditsa Levanon; Varda Negreanu; Dena Leshkowitz; Gilgi Friedlander; Yoram Groner
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

10.  CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.

Authors:  Andrea Moreno-Manuel; Eloisa Jantus-Lewintre; Ines Simões; Fernando Aranda; Silvia Calabuig-Fariñas; Esther Carreras; Sheila Zúñiga; Yvonne Saenger; Rafael Rosell; Carlos Camps; Francisco Lozano; Rafael Sirera
Journal:  Transl Lung Cancer Res       Date:  2020-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.